Builds on Celularity’s December 2022 announcement of Halal Certification of its commercial-stage biomaterial products, and clinical and investigational.
Celularity Inc. (NASDAQ:CELU – Get Rating) saw a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 3,790,000 shares, a drop of 26.7% from the March 31st total of 5,170,000 shares. Approximately 5.4% of the company’s shares are sold short. Based on an average daily […]
Celularity Inc. (NASDAQ:CELU – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 5,170,000 shares, an increase of 8.8% from the March 15th total of 4,750,000 shares. Based on an average daily volume of 570,100 shares, the days-to-cover […]
Celularity Inc. (NASDAQ:CELU – Get Rating) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 5,170,000 shares, a growth of 8.8% from the March 15th total of 4,750,000 shares. Approximately 7.4% of the company’s shares are short sold. Based on […]
Celularity Inc. (NASDAQ:CELU – Get Rating) was the target of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 4,750,000 shares, a growth of 38.1% from the February 28th total of 3,440,000 shares. Currently, 9.2% of the company’s shares are sold short. Based on […]